Back to mobile site

Deutsche Bank Starts Tesaro (TSRO) at Buy; Best in Class Drug

February 6, 2013 7:12 AM EST Send to a Friend
Deutsche Bank initiates coverage on Tesaro (NASDAQ: TSRO) with a Buy. PT $27.00.

The firm comments, "Tesaro is developing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login